Abstract:Background: The transformation of chronic inflammation into adenocarcinoma in stomach lacks specific molecular markers to monitor early cancer development and effective drugs for early intervention. In this study, we identified two key genes, LYZ (encoding lysozyme) and SST (encoding somatostatin). Methods: LYZ and SST was identified by integrating high-throughput sequencing data derived from patients related to gastritis-cancer and microarray data of The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) databases. Their expression was verified in human specimens and rat model of gastritis-cancer. The clinicopathological significance study for predicting the progression of chronic gastritis to cancer transition and cancer prognosis was using ROC curve, survival and correlation analysis. Their expression difference was tested in patients those received effective interventions, based on a multicenter randomized control clinical trial for precancerous disease in stomach. Findings: LYZ and SST were consistently downregulated in the process of chronic inflammation into adenocarcinoma in stomach. The ROC curves of these genes had a great value in predicting precancerous disease and gastric cancer independently and in combination. Their expression levels were correlated with gastritis and intestinal metaplasia staging, and would increase after effective intervention in precancerous patients. Interpretation: We identified LYZ and SST as key “hub” genes for chronic gastritis to cancer transition, promising biomarkers of significant clinical predictive value, and potential targets for inhibiting gastric cancer development. Trial Registration: ChiCTR-IOR-16008027Funding Statement: National Natural Science Foundation of China (No.81703931, 81973819) Natural science foundation of Guangdong province in 2017 (2017A030310121) Natural science foundation of Guangdong province in 2019 (2019A1515011145) Breakthrough Project of TCM Dominant Diseases with Special Funds for Strengthening Traditional Chinese Medicine in 2015 (No.19), Guangdong Administration of Traditional Chinese Medicine. Major Projects of First-Class Disciplines in Guangzhou University of TCM in 2018 (A1-AFD018181A27). Major Research Projects of Guangzhou University in TCM in 2019 (A1-2606-19-110-007). Innovative Research Team Project of Innovation Hospital in the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine in 2017 (2017TD05). Youth Scientific Research Talents Training Program of Innovation Hospital in the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine in 2015 (2015QN09). The Second Batch of Clinical Research Program of Innovation Hospital Phase II project in the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine in 2019 (2019IIT19). Declaration of Interests: The authors declare no conflicts.Ethics Approval Statement: The ethics committee of the first affiliated hospital of Guangzhou University of Traditional Chinese Medicine approved this study (approval number ZYYECK [2015]024-ND-01, ZYYECK [2017]023-XZ-01, ZYYECK [2019]015).The ethics committee of the first affiliated hospital of Guangzhou University of Traditional Chinese Medicine approved this study (approval number ZYYECK [2015]024-ND-01).The rat study design and protocol were approved by the animal ethics committee of Beijing University of Chinese Medicine, China (No. BUCM-4-2018060403-2007).

Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice

Streptococcus anginosus: A new pathogen of superficial gastritis, atrophic gastritis and gastric cancer

Streptococcus anginosus in the development and treatment of precancerous lesions of gastric cancer

Characterization of the landscape of the intratumoral microbiota reveals that Streptococcus anginosus increases the risk of gastric cancer initiation and progression

Oral streptococci S. anginosus and S. mitis induce distinct morphological, inflammatory, and metabolic signatures in macrophages

A potential new player in gastric cancer

Helicobacter pylori-Induced Angiopoietin-Like 4 Promotes Gastric Bacterial Colonization and Gastritis

Porphyromonas Gingivalis Lipopolysaccharide Damages Mucosal Barrier to Promote Gastritis-Associated Carcinogenesis.

The Cxcr2+ subset of the S100a8+ gastric granylocytic myeloid-derived suppressor cell population (G-MDSC) regulates gastric pathology

Tubulointerstitial nephritis antigen-like 1 is a novel matricellular protein that promotes gastric bacterial colonization and gastritis in the setting of Helicobacter pylori infection

Morphological and Pathologic Changes of Experimental Chronic Atrophic Gastritis (CAG) and the Regulating Mechanism of Protein Expression in Rats

Stools from Colorectal Cancer Patients Promote Intestinal Carcinogenesis in Animal Models Through Inducing Th17-Mediated Inflammation

Streptococcus mutans promotes tumor progression in oral squamous cell carcinoma

Gastrin is an Essential Cofactor for Helicobacter-Associated Gastric Corpus Carcinogenesis in C57bl/6 Mice

Angiotensin Ii Promotes the Progression of Human Gastric Cancer

Helicobacter pylori infection induces abnormal expression of pro-angiogenic gene ANGPT2 and miR-203a in AGS gastric cell line

Chronic CagA-positive Helicobacter Pylori Infection with MNNG Stimulation Synergistically Induces Mesenchymal and Cancer Stem Cell-Like Properties in Gastric Mucosal Epithelial Cells

Ang1 and Ang4 differentially affect colitis and carcinogenesis in an AOM-DSS mouse model

LYZ and SST Prevent the Progression of Chronic Inflammation into Adenocarcinoma in the Stomach

Mucosal-Associated Invariant T Cells Augment Immunopathology and Gastritis in Chronic Helicobacter pylori Infection

New pathogen on the block